COMING SOON
Product photography in progress
◷ Coming Soon — photo on its way10 mg
Effortless Appetite Control
Tirzepatide Pen
R969
Appetite-Pathway Research. Body-Composition Endpoints. Energy-Metabolism Markers.
One molecule, two pathways — the dual GIP/GLP-1 agonist studied across appetite and metabolism research. For research purposes only.
Size / Option
SupplyUp To 8 Weeks
BAC water3 ml included
Not available to order yet — photo & stock landing shortly.
Appetite ControlEasier Fat LossSteady EnergyBlood Sugar Support
Dual-action peptide that curbs cravings and drives steady weight loss
Certificate of Analysis
Every vial is independently tested for purity — with its CoA on file.
Tirzepatide Pen · AssayedPurity
98.7%
Batch
TZP-PEN-2601A
Mol. Weight
4813.5 g/mol
01Overview
Why You'll Love Tirzepatide Pen
Tirzepatide is investigated as a dual GIP/GLP-1 receptor agonist, studied for its action across two appetite- and metabolism-related pathways at once — a focus of intense energy-metabolism and body-composition research. Supplied as a premium, high-purity 10 mg vial verified for content and prepared for clean, accurate reconstitution, so the material behind every experiment is consistent batch after batch. Supplied strictly for research purposes only — not a weight-loss product and not for human use.
- Pre-filled, pre-reconstituted — ready to use
- Strong appetite suppression
- Steady, consistent weight loss
- Better blood sugar control
- Longer-lasting fullness
- Improved metabolic health
Also known as
Tirzepatide PenLY3298176Dual Agonist Peptide
02What You'll Notice
The journey, week by week
A week-by-week guide to what people tend to notice over a typical cycle.
1
Weeks 1-4
Starting Phase
Research protocols open at a gentle 1.25 mg weekly to establish a baseline before escalation.
Pre-filled, pre-reconstituted — ready to use
2
Weeks 5-8
Building
Stepping to 2.5 mg weekly — the range in which appetite- and metabolism-pathway endpoints begin to be assessed.
Strong appetite suppression
3
Weeks 9-12
Peak
At 5 mg weekly, the window most frequently referenced in energy-metabolism research models.
Steady, consistent weight loss
★
Weeks 13+
Advanced
Extended schedules up to 7.5 mg weekly complete an extended research cycle before review.
Better blood sugar control
For research purposes only. Timelines reflect published research models — not medical advice or expected personal outcomes.
03Customer Reviews
Ratings & reviews
No reviews yet
Be the first to review Tirzepatide Pen
We publish every review we receive, exactly as written. Yours will be the first — no account needed.
04Usage & Handling
How it is handled in the lab
Research Administration
Pre-filled subcutaneous auto-injector, dose-escalation starting at 2.5 mg weekly in research models
New to peptides?Reconstitution calculatorGlossaryHow-to guides
05Important Notices
Storage, stability & what this is sold for
For research purposes only. Not for human consumption.
- Store at −20°C in a dry, sealed environment
- Reconstitute with bacteriostatic water; use within 30 days at 4°C
- Avoid repeated freeze-thaw cycles
- Supplied for research purposes only — not for human or veterinary use
06Complete the Bench